DAFTAR PUSTAKA

1. Gonzalez A, Spearman, Stoll B. Neonatal infectious disease: Evaluation of neonatal

sepsis. Pediatr Clin N Am. 2013.

2. Rohsiswatmo R. Kontroversi diagnosis sepsis neonatorum. Dalam: Penyuting

Hegar.B, Trihono P, Ifran EB. Update in neonatal infection. Departemen Ilmu kesehatan

Anak FKUI RSCM ,Jakarta desember 2005. Hal 32 -43.

3. Roeslani D R, Amir I, Nasrulloh H, Suryani. Penelitian awal: Faktor risiko pada sepsis

neonatorum awitan dini. Sari Pediatri, Vol. 14, No. 6, April 2013.

4. Leal Y , Álvarez-Nemegyei J , Velázquez J , Rosado-Quiab , Diego-Rodríguez N , Paz-

Baeza E, et.al. Risk factors and prognosis for neonatal sepsis in southeaster mexico:

analysis of a four year historic cohort follow up. BMC Pregnancy and Childbirth 2012,

12 :48. http://www.biomedcentral.com/1471-2393/12/48

5. Qazi A S, Stoll B. Neonatal Sepsis : Major Global Public Health Challenge. The

Pediatric Infectious Disease Journal . Volume 28, Number 1, January 2009

6. Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo G, Messner H, et.al. Bovine

Lactoferrin supplementation for prevention of late onset sepsis in very low birth wight

neonates: a randomized trial. JAMA, October 7,2009- volume 302, No.13. diakses dari

http:jama.jamanetwork.com/on09/17/2013

7. Freitas R, Leão R, Gomes, Batista R. Nutrition therapy and neonatal sepsis. Rev Bras Ter

Intensiva. 2011; 23(4):492-498.

8. Cohen-Wolkowiez M, Benjamin DK, Capparelli E. Immunotherapy in neonatal sepsis:

advances in treatment and prophylaxis. Curr Opin Pediatr. 2009 ; 21(2) : 177–81.

9. Embleton, Berrington J, McGuire W, Stewart M, Cummings S. Lactoferrin:

Antimicrobial activity and therapeutic potential. Seminars in Fetal & Neonatal Medicine

xxx (2013) 1-7.

10. Venkatesh MP, Rong L. Human recombinant lactoferrin acts synergistically with

antimicrobials commonly used in neonatal practice against coagulase-negative

staphylococci and Candida albicans causing neonatal sepsis. Journal of Medical

Microbiology 2008 ; 57 : 1113–2

11. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995 ; 80 : 252-67.

12. Yunanto A, Andayani, Triyawanti P, Suhartono E, Widodo A. Neutrophil Phagocytosis

Activity Compared To Myeloperoxidase, Hydrogen Peroxidase And Lactoferrin Levels

In Saliva Of Newborn Baby With Sepsis Risk Factors To Detect Early-Onset Neonatal

Sepsis. International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 –

6718, ISSN (Print): 2319 – 670X .. Volume 2 Issue 1 ‖ January 2013 ‖PP.18-22, diakses

dari ww.ijpsi.org

13. Jiang Z, Ye.G. 1:4 matched case-controlstudy on influential factor of early onset neonatal

sepsis. European Review for Medical and Pharmacological Sciences. 2013; 17: 2460-

2466.

14. Haque KN. Definitions of Bloodstream Infection in the Newborn.Pediatr Crit Care

Med 2005; 6: S45-9

15. Rodrigo I. Changing patterns of neonatal sepsis. Sri Lanka J Child Health 2002;

31: 3-8.

16. Aminullah A. Masalah terkini sepsis neonatorum. Dalam: Penyuting Hegar.B, Trihono P,

Ifran EB. Update in neonatal infection. Departemen Ilmu kesehatan Anak FKUI

RSCM ,Jakarta desember 2005. Hal 1-15

17. Amir I, Rundjan L. Patofisiologi sepsis Neonatorum : Systemic Inflamatory response

syndrome (SIRS). Dalam: Hegar.B, Trihono P, Ifran EB,Penyuting. Update in neonatal

infection. Departemen Ilmu kesehatan Anak FKUI RSCM ,Jakarta desember 2005. Hal

17-31

18. Cinel Ismail, Steven M. Opal. Molecular biology of inflammation and sepsis: A primer.

Crit Care Med 2009 Vol. 37, No. 1

19. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates.

Nature Review . Immunology. Volume 7, M ay 2010.

20. Chirico G. Development of the Immune System in Neonates. J Arab Neonatal Forum

2005; 2: 5-11.

21. Short MA. Linking The Sepsis Triad of Inflammation, Coagulation and Suppressed

Fibrinolysis to Infants. Adv Neonat Care 2004 ; 5:258-73.

22. Pierrakos . Charalampo, Louis Vincent. Jean. Sepsis biomarkers: a review. Pierrakos and

Vincent Critical Care 2010, 14:R15. http://ccforum.com/content/14/1/R15

23. Shapiro Philipp Schuetz , Yano K, Sorasaki M, Parikh S, Jones Ella, et al. The

association of endothelial cell signaling severity of illness, and organ dysfunction in

sepsis . Critical Care 2010, 14:R182 . http://ccforum.com/content/14/5/R182

24. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed

2004; 89: F229-F235. doi: 10. 1136/adc.2002.023838.

25. González-Chávez SA, Arévalo-Gallegos S, Rascón-Cruz Q. Lactoferrin: structure,

function and applications. International Journal of Antimicrobial Agents 2009 ; 33 :

301.e1 - 8.

26. Conneely O. Review: Antiinflammatory Activities of Lactoferrin. Journal of the

American College of Nutrition, Vol. 20, No. 5, 389S–395S (2001)

27. Adlerova L, Bartoskova A, Faldyna M. Lactoferrin: a review. Veterinarni Medicina, 2008

; 53 (9): 457–68.

28. Roşeanu A, Damian M, Evans RW. Mechanisms of the antibacterial activity of

lactoferrin and lactoferrin-derived peptides. Rom. J. Biochem. 2010 ; 47 (2) : 203–9.

29. Farnaud S, Evans RW. Lactoferrin - a multifunctional protein with antimicrobial

properties. Molecular Immunology 2003 ; 40 : 395 – 405.

30. Conneely O. Review: Antiinflammatory Activities of Lactoferrin. Journal of the

American College of Nutrition, Vol. 20, No. 5, 389S–395S (2001)

31. Kaufman D, Lactoferrin Supplementation to Prevention Nosocomial Infections in

Preterm Infants AMA, October 7, 2009—Vol 302, No. 13. http://jama.jamanetwork.com/

on 07/12/2012

32. Kruzel M, Zimecki M. Lactoferrin and Immunologic Dissonance: Clinical Implications.

Archivum Immunologiae et Therapies Experimentalis. 2002, 50, 399–410

33. Jenssen, R.E.W. Hancock. Antimicrobial properties of lactoferrin. Biochimie 91 (2009)

19-29.

34. Romeo, Bollani L, Rinaldi M, Gallo E, Quercia M, Manzoni M, et.al. Lactoferrin

Prevents Invasive Fungal Infections in Very Low Birth Weight Infants: A Randomized

Controlled Trial. Pediatrics, Volume 129, Number 1, January 2012.

35. Stewart C J, Nelson A, Scribbins D, Marrs E, Lanyon C, Embleton N, et.al. Bacterial and

fungal viability in the preterm gut: NEC and sepsis. Arch dis child fetal neonatal ed 2013

page 1-6